A Quantitative Promoter Methylation Profile of Prostate Cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-04-0894PMID 15623627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours

  2005cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.

  2004cited by this paper
• Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

  2003cited by this paper
• Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.

  2003cited by this paper
• Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.

  2003cited by this paper
• Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.

  2003cited by this paper
• Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.

  2003cited by this paper
• Altered methylation of multiple genes in carcinogenesis of the prostate

  2003cited by this paper
• Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.

  2003cited by this paper
• Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone

  2002cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002cited by this paper
• Frequent hypermethylation of the RASSF1A gene in prostate cancer

  2002cited by this paper
• Emerging molecular markers of cancer

  2002cited by this paper
• The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.

  2002cited by this paper
• Hierarchical clustering of lung cancer cell lines using DNA methylation markers.

  2002cited by this paper
• Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.

  2002cited by this paper
• Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.

  2002cited by this paper
• Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

  2002influential reference
• Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.

  2001cited by this paper
• Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

  2001cited by this paper
• Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

  2001cited by this paper
• Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.

  2001cited by this paper
• The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention.

  2001cited by this paper
• Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

  2001cited by this paper
• Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version

  2001cited by this paper
• Benign prostatic hyperplasia and prostate cancer.

  2001cited by this paper
• Cellular and Molecular Pathology of Prostate Cancer Precursors

  2000cited by this paper
• Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.

  2000cited by this paper
• Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.

  1999influential reference
• Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

  1998cited by this paper
• Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer

  1997cited by this paper
• Prognostic factors for clinically localized prostate carcinoma

  1997cited by this paper
• Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma.

  1996cited by this paper
• A modified and improved method for bisulphite based cytosine methylation analysis.

  1996cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper

• International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.

  2025cites this paper
• Selective adsorption of unmethylated DNA on ZnO nanowires for separation of methylated DNA.

  2025cites this paper
• A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer

  2025cites this paper
• Prostate cancer epigenetics - from pathophysiology to clinical application.

  2025cites this paper
• Methylation status of GSTP1 and APC promoter genes as potential biomarkers for early detection and tumor aggressiveness in prostate cancer: insights from a Moroccan cohort

  2025cites this paper
• UHRF1 phase separation mediates stable inheritance of DNA methylation and promotes the proliferation of prostate cancer cells

  2025cites this paper
• DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications

  2025cites this paper
• Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoring

  2024cites this paper
• Factors Involved in Prostate Cancer Disparity in African Americans: from Health System to Molecular Mechanisms

  2024cites this paper
• The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer

  2024cites this paper
• Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer

  2023cites this paper
• Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.

  2023cites this paper
• Molecular heterogeneity in prostate cancer and the role of targeted therapy.

  2023cites this paper
• Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer

  2023cites this paper
• Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation

  2022cites this paper
• From Therapy Resistance to Targeted Therapies in Prostate Cancer

  2022cites this paper
• Physical exercise increases global and gene‐specific (interleukin‐17 and interferon‐γ) DNA methylation in lymphocytes from aged women

  2021cites this paper
• Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis

  2021cites this paper
• The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review

  2021cites this paper
• Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer

  2021cites this paper
• Dihydroartemisinin induces cell apoptosis through repression of UHRF1 in prostate cancer cells

  2021cites this paper
• Molecular pathogenesis of prostate cancer

  2020cites this paper
• Aberrant SOCS3 Promoter Methylation as a Noninvasive Diagnostic Biomarker for Locally Advanced Prostate Cancer

  2020cites this paper
• The diagnostic value of RASSF1A promoter methylation in prostate cancer: A systematic review and meta-analysis

  2020cites this paper
• Autoencoded DNA methylation data to predict breast cancer recurrence: Machine learning models and gene-weight significance

  2020cites this paper
• Epigenetic modifications in prostate cancer

  2020cites this paper
• Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.

  2020cites this paper
• Classification of Medical Images using Artificial Neural Network

  2020cites this paper
• Epigenetic heterogeneity in cancer

  2019cites this paper
• Chronic inflammation evoked by pathogenic stimulus during carcinogenesis

  2019cites this paper
• Prostate Cancer Energetics and Biosynthesis.

  2019cites this paper
• Methylation of global DNA repeat LINE-1 and subtelomeric DNA repeats D4Z4 in leukocytes is associated with biochemical recurrence in African American prostate cancer patients.

  2019cites this paper
• Disparities in prostate cancer incidence and mortality rates: Solvable or not?

  2019cites this paper
• Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells

  2019cites this paper
• Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

  2019cites this paper
• Towards a personalised medicine strategy to reduce prostate cancer risk in men

  2018cites this paper
• Genetics in the Prostate Cancer

  2018cites this paper
• Epigenetic Signatures in the Diagnosis and Prognosis of Cancer

  2018cites this paper
• Methylation and MicroRNA Profiling to Understand Racial Disparities of Prostate Cancer.

  2018cites this paper
• Genetics in the Prostate Cancer Genetics in the Prostate Cancer

  2018cites this paper
• Precision Molecular Pathology of Prostate Cancer

  2018influential citation
• Adenomatous Polyposis Coli Regulates Epithelial Membrane Protein 2 to Mediate 3D Morphogenesis and Apical-Basal Polarity

  2018cites this paper
• Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)

  2018influential citation
• Targeting DNA Methyltranferases in Urological Tumors

  2018influential citation
• Epigenetic Alterations in Primary Prostate Cancer

  2018cites this paper
• Molecular markers for prostate cancer

  2018cites this paper
• Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients

  2017cites this paper
• Phosphatidylserine: A cancer cell targeting biomarker.

  2017cites this paper
• METHYLATION OF GAL3 PROMOTER FOR EARLY DAGNOSIS OF PROSTATE CANCER

  2017cites this paper
• Prostate Cancer : A Case ‐ Control Study

  2017cites this paper
• Emerging epigenetics in cancer chemoprevention by dietary phytochemicals

  2017cites this paper
• Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns

  2017cites this paper
• Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients

  2017cites this paper
• DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects

  2016cites this paper
• One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling

  2016cites this paper
• Association between hypermethylation of the SFRP 1 promoter and cervical cancer in Han and Uyghur patients from Xinjiang

  2016cites this paper
• A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers

  2016cites this paper
• Epigenetic modulators as therapeutic targets in prostate cancer

  2016cites this paper
• Methylation status of homeobox genes in common human cancers.

  2016cites this paper
• Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis

  2016cites this paper
• Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.

  2016cites this paper
• DNA Methylation Alterations as Biomarkers for Prostate Cancer

  2016cites this paper
• Epigenetic Alterations in Endocrine-Dependent Cancers: Implications of Endocrine Dysfunctions

  2016cites this paper
• p16 upregulation is linked to poor prognosis in ERG negative prostate cancer

  2016cites this paper
• Mutations in regulators of the epigenome and their effects on the DNA methylome

  2016cites this paper
• PERSPECTIVAS ACTUALES DE LA BIOLOGÍA MOLECULAR APLICADA A LA URO-ONCOLOGÍA THE ROLE OF METHYLATION IN UROLOGICAL TUMOURS

  2015cites this paper
• Biomarkers for prostate cancer: present challenges and future opportunities

  2015cites this paper
• Clinical utility of RASSF1A methylation in human malignancies

  2015cites this paper
• The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma

  2015cites this paper
• A urine-based methylation signature for risk stratification within low-risk prostate cancer

  2015cites this paper
• Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers

  2015cites this paper
• Association of p 16 gene methylation with prostate cancer risk : a meta-analysis

  2015cites this paper
• Clinical Study Frequent DNAHypermethylation at the RASSF 1 A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin

  2015influential citation
• Fully Bayesian T-probit Regression with Heavy-tailed Priors for Selection in High-Dimensional Features with Grouping Structure

  2015cites this paper
• Multigene Methylation Biomarker Analysis in Prostate Cancer

  2015cites this paper
• DNA Methylation and Flavonoids in Genitourinary Cancers

  2015cites this paper
• Targeting the genes of 9p13.3 amplicon in prostate cancer

  2015cites this paper
• Epigenetic Biomarkers in Personalized Medicine

  2015cites this paper
• Promoter hypermethylation as a biomarker in prostate adenocarcinoma.

  2015cites this paper
• Integrated Analysis and Application Pipelines for Complex Disease Data

  2015cites this paper
• Diagnostic and prognostic epigenetic biomarkers in cancer.

  2015cites this paper
• Association of p16 gene methylation with prostate cancer risk: a meta-analysis.

  2015cites this paper
• Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection

  2015cites this paper
• Aberrant DNA Methylation of Ribosomal RNA Genes in Human Cancer

  2015cites this paper
• A Study of Molecular Signals Deregulating Mismatch Repair Genes in Prostate Cancer Compared to Benign Prostatic Hyperplasia

  2015cites this paper
• EMT and tumor metastasis

  2015cites this paper
• Changes of protein expression in prostate cancer having lost its androgen sensitivity

  2015cites this paper
• Exploiting APC function as a novel cancer therapy.

  2014cites this paper
• Association of DSC3 mRNA Down-Regulation in Prostate Cancer with Promoter Hypermethylation and Poor Prognosis

  2014cites this paper
• Epigenetic biomarkers in urological tumors: A systematic review.

  2014cites this paper
• Prognostic value of RASSF1 promoter methylation in prostate cancer.

  2014cites this paper
• Epigenetic alterations in endocrine-related cancer.

  2014cites this paper
• Anti-neoplastic properties of hydralazine in prostate cancer

  2014cites this paper
• Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer

  2014cites this paper
• Avaliação da taxa de metilação do DNA em região promotora e de vitaminas e citocinas em mulheres com história de abortos recorrentes

  2014cites this paper
• Frequency of P 16 INK 4 a and P 14 ARF genes methylation and its impact on bladder cancer cases in north Indian population

  2014cites this paper
• The role of RASSF 1 A methylation in cancer

  2014cites this paper
• The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies

  2014cites this paper
• Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.

  2014cites this paper
• Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.

  2014cites this paper